These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment. Stokes JB; Adair SJ; Slack-Davis JK; Walters DM; Tilghman RW; Hershey ED; Lowrey B; Thomas KS; Bouton AH; Hwang RF; Stelow EB; Parsons JT; Bauer TW Mol Cancer Ther; 2011 Nov; 10(11):2135-45. PubMed ID: 21903606 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma. Stewart JE; Ma X; Megison M; Nabers H; Cance WG; Kurenova EV; Beierle EA Mol Carcinog; 2015 Jan; 54(1):9-23. PubMed ID: 23868727 [TBL] [Abstract][Full Text] [Related]
8. MYCN, neuroblastoma and focal adhesion kinase (FAK). Beierle EA Front Biosci (Elite Ed); 2011 Jan; 3(2):421-33. PubMed ID: 21196322 [TBL] [Abstract][Full Text] [Related]
9. Targeting focal adhesion kinase in neuroblastoma. Gillory L; Beierle EA Anticancer Agents Med Chem; 2010 Dec; 10(10):714-21. PubMed ID: 21269252 [TBL] [Abstract][Full Text] [Related]
10. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells. Tanaka N; Fukuzawa M Int J Oncol; 2008 Oct; 33(4):815-21. PubMed ID: 18813796 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of Axl in non-MYCN amplified neuroblastoma cell lines reduces migration. Duijkers FA; Meijerink JP; Pieters R; van Noesel MM Gene; 2013 May; 521(1):62-8. PubMed ID: 23523856 [TBL] [Abstract][Full Text] [Related]
12. Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts. Stafman LL; Williams AP; Marayati R; Aye JM; Markert HR; Garner EF; Quinn CH; Lallani SB; Stewart JE; Yoon KJ; Whelan K; Beierle EA Sci Rep; 2019 Sep; 9(1):13259. PubMed ID: 31519958 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells. Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091 [TBL] [Abstract][Full Text] [Related]
14. Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma. Bogen D; Wei JS; Azorsa DO; Ormanoglu P; Buehler E; Guha R; Keller JM; Mathews Griner LA; Ferrer M; Song YK; Liao H; Mendoza A; Gryder BE; Sindri S; He J; Wen X; Zhang S; Shern JF; Yohe ME; Taschner-Mandl S; Shohet JM; Thomas CJ; Martin SE; Ambros PF; Khan J Oncotarget; 2015 Nov; 6(34):35247-62. PubMed ID: 26497213 [TBL] [Abstract][Full Text] [Related]
15. Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma. Henriksen JR; Haug BH; Buechner J; Tømte E; Løkke C; Flaegstad T; Einvik C BMC Dev Biol; 2011 Jan; 11():1. PubMed ID: 21194500 [TBL] [Abstract][Full Text] [Related]
16. FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors. Megison ML; Gillory LA; Stewart JE; Nabers HC; Mrozcek-Musulman E; Beierle EA Mol Cancer Res; 2014 Apr; 12(4):514-26. PubMed ID: 24464916 [TBL] [Abstract][Full Text] [Related]
17. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration. Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367 [TBL] [Abstract][Full Text] [Related]
18. Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma. Regan PL; Jacobs J; Wang G; Torres J; Edo R; Friedmann J; Tang XX Int J Oncol; 2011 Jan; 38(1):105-12. PubMed ID: 21109931 [TBL] [Abstract][Full Text] [Related]
19. Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer. Hao HF; Takaoka M; Bao XH; Wang ZG; Tomono Y; Sakurama K; Ohara T; Fukazawa T; Yamatsuji T; Fujiwara T; Naomoto Y Biochem Biophys Res Commun; 2012 Jul; 423(4):744-9. PubMed ID: 22705303 [TBL] [Abstract][Full Text] [Related]
20. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway. Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]